Slide 1: Precision Optics Corporation
Precision Optics Corporation NASDAQ: POCI May 2026
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activ
Slide 3: Enabling Next Generation Technologies
Enabling Next Generation Technologies Precision Optics is a VERTICALLY INTEGRATED OPTICS COMPANY primarily focused on leveraging its proprietary MICRO-OPTICS AND IMAGING TECHNOLOGIES to the HEALTHCARE and DEFENSE/AEROSPACE industries by providing services ranging from new product concept through mas
Slide 4: Business Model
Business Model ►Business model driving rapid growth ►Work closely with key medical device and defense companies at the very early design stage of projects, lending the Company’s expertise in proprietary micro-optics, 3D imaging, and digital imaging technologies ►Robust pipeline supporting future com
Slide 5: Revenue Ramp
Revenue Ramp FY End June $35 $29 M- $31 M $30 FY 2026 Guidance $25 $21.0 $20 $19.1 $19.1 $15.7 $15 YTD $14.3 $10.8 9 Mo. $10.7 $14.1 March $9.9 $22.8 2026 $10 $10.3 $6.8 $7.9 $5 $4.0 $8.5 $3.2 $5.5 $8.3 $2.8 $5.4 $6.7 $1.8 $5.0 $1.4 $1.3 $1.4 $2.8 $0 $1.3 2017 2018 2019 2020 2021 2022 2023 2024 2025
Slide 6: Leader in Micro, Ultra-High Precision, Digital Imaging
LEADER IN MICRO, ULTRA-HIGH PRECISION, DIGITAL IMAGING
Slide 7: Differentiated Product Technology Offerings
Differentiated Product Technology Offerings Micro Optics 3D Imaging & Ultra-High Precision Digital Imaging 7
Slide 8: MicroPrecision Optics
MicroPrecision Optics ► Millimeter sized and smaller cameras with low manufacturing costs ► Small size can provide visualization for new procedures in new parts of the body and for existing procedures that are currently performed blind or with sub-optimal imaging. Facilitates the development of new
Slide 9: 3D Endoscopes and Ultra-High Precision
3D Endoscopes and Ultra-High Precision ► One of only a handful of companies in the world to design and provide 3D endoscopes ► Precision Optics 3D endoscopes provide next generation optical imaging for minimally invasive surgical procedures, many employing medical robotic technology, by using the br
Slide 10: Digital Imaging Electronics and Systems
Digital Imaging Electronics and Systems ► With the growing movement towards CMOS sensors in next generation devices, imaging system electronics are becoming increasingly critical to creating optimal solutions to our customer’s requirements. ► Our product development team has extensive experience dev
Slide 11: Key Markets: Medical Device Market
Key Markets: POC Has Supported The Medical Device Market For Many Years ►MicroPrecision Optics ►Smaller imaging systems enabling next generation minimally invasive surgery ►3D Endoscopes & Ultra-High Resolution ►Robotic Surgery ►4K Imaging ►AR/VR, fluorescense ►Digital Imaging ►Full medical device s
Slide 12: Key Markets: Defense / Aerospace
Key Markets: POC Is Increasing Engagement with Defense / Aerospace ►SWaP (Size Weight and Power) ►Areas of Focus ►Satellite communications (15-25% CAGR) ►UAV/Drones ►Directed energy weapons 12
Slide 13: Recent Large Orders
Recent Large Orders ►Single-Use Cystoscopy Program ►Top Tier Aerospace Program Program leverages POC’s technology to supply single-use Program leverages POC’s proprietary manufacturing technology endoscope assemblies used in a cystoscopy surgery system developed for high precision micro-optics syste
Slide 14: Digital Imaging Systems – Horizontally Integrated
Digital Imaging Systems – Horizontally Integrated Optics Image Sensor Illumination Video Processing Packaging System Performance Performance Luminance Quality Sterilization Product Cost Size Size Distribution Flexibility Biocomp. Quality Fabrication Interconnect Power & Thermal Latency Size Complian
Slide 15: Vertically Integrated Design to Manufacture
Vertically Integrated Design to Manufacture Broad Optical Capabilities All Under One Roof Onsite Engineering, Design To Design For Rapid Development Material Efficient High Volume Machine Shop, Production Manufacturability Of New Concepts Sourcing Manufacturing Production Optics Lab & Assembly Engin
Slide 16: Unity Platform
Unity Platform ►Groundbreaking modular optical platform is set to transform the development and production of endoscopic imaging devices by significantly reducing costs, time to market, and project risks ►Standard baseline CMOS endoscopic system with customization options based on existing or newly
Slide 17: Expanding Product Development Pipeline
Expanding Product Development Pipeline Feasibility Prototype Prototype Verification/ Product Production Industry Subsegment Customer Study Design Fabrication Validation Multiple Mature “Legacy” Products Medical Device Multiple Multiple Cystoscope #1 Medical Device Cystoscopy Large Medical Device Opt
Slide 18: Go Forward Strategy
Go Forward Strategy Continue expansion of Advance pipeline projects to production lines commercialization Expand product Disciplined investments in development pipeline sales and marketing, as well leveraging Unity Platform as technical capabilities Look for strategic acquisitions Expand and update
Slide 19: Financials
FINANCIALS
Slide 20: Financial Snapshot
Financial Snapshot FY End 6/30, $ in millions Revenue Gross Margins Adjusted EBITDA $0.5 $29-$31 $0.0 37% 37% ($0.0) ($0.0) 34% ($0.2) $21.0 $19.1 $19.1 ($0.8) 32% 30% 31% 31% $15.7 ($1.6) $10.7 $9.9 $6.8 ($2.5) - 18% ($2.7) $4.0 ($3.7) FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26 FY18 FY19 FY20 FY2
Slide 21: Quarterly Financial Snapshot
Quarterly Financial Snapshot Quarterly FY ends June Revenue Gross Margins $ Million Adjusted EBITDA $ Million $10 $0.4 $0.3 24% $9 $8.7 $0.2 $8 $0.0 $7.4 $7 $6.7 ($0.2) $6 ($0.4) 14% $5 ($0.6) $4 ($0.8) $3 ($1.0) $2 ($1.2) ($1.2) $1 3% ($1.4) ($1.5) $0 ($1.6) Q1 2026 Q2 2026 Q3 2026 Q1 2026 Q2 2026
Slide 22: Income Statement Highlights
Income Statement Highlights FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 Q1 Q2 Q3 Q4 FY 2025 Q1 Q2 Q3 Revenues 9,923,356 10,674,907 15,678,248 21,044,467 19,104,349 4,197,053 4,526,907 4,185,968 6,181,342 19,091,269 6,680,823 7,367,837 8,708,631 Cost of Goods Sold 6,560,779 7,241,323 10,750,061 13,310,33
Slide 23: Balance Sheet Highlights
Balance Sheet Highlights 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 3/31/2026 Cash and cash equivalents $1,134,697 $861,650 $605,749 $2,925,852 $405,278 $1,773,735 $10,680,046 Accounts receivable, net $1,481,437 $1,878,755 $2,663,872 $3,907,407 $3,545,491 $4,336,730 $6,577,866 Inven
Slide 24: Thank You
THANK YOU